Subscribe to RSS
DOI: 10.1055/s-0043-1768937
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature
Hematohidrosis, or hematidrosis, is a rare medical condition characterized by blood oozing from the intact skin in the absence of a bleeding problem.[1] Prior to modern-day medical literature, these phenomena had been captured in Renaissance and also present-day artwork. While the purpose of medical literature is to aid healthcare professionals and patients in the better understanding and treatment of disease, a significant proportion of Renaissance art commissioned by the church depicted scenes from the Bible, for the purposes of a visual depiction of key events to promote teachings of the faith, and to encourage devotion to God.
We explored the theme of hematohidrosis in historic art and performed a rapid review of modern medical literature, noting that the earliest works featuring hematohidrosis were depictions in Renaissance art as early as the 15th century. The German painter known as Meister Der Freisinger Passion (Master of the Freising Passion) depicts Jesus Christ in the Garden of Gethsemane at the foot of the Mount of Olives, sweating drops of blood ([Fig. 1]). Around him, his disciples sit, fast asleep. Another piece given the same name, the Christus am Ölberg, is featured in one of the frescoes of the Tabernakelbildstock in Welsberg-Taisten (Wayside Shrine of Tesido; [Fig. 2]). Believed to have been painted by Wolfgang Sauber in the 1460s, it depicts Christ with his hands clasped together in prayer as bloody sweat dots his forehead. These two artworks provide visual testimony to Luke's account of the Gospel of Jesus Christ praying in the Garden of Gethsemane before crucifixion. The motif of the cup is featured in the two artworks, echoing Christ's words in Luke 22:42, “Father, if you are willing, remove this cup from me. Nevertheless, not My will, but Yours, be done.” The cup is a symbol of the cup of God's wrath that Jesus takes upon Himself, as He takes on the sins of the nations. In the words of preacher Charles Spurgeon, “at one tremendous draught of love, He drank damnation dry.” Luke tells us that “being in agony, He prayed more earnestly; and His sweat became like great drops of blood falling down to the ground” (Luke 22:45). This was likely the first documented case report of hematohidrosis in the existing literature. Given Luke's background as a physician, this could possibly explain his attention to medical detail that is otherwise not reported in the other Gospels. In an era where the lay people were largely illiterate and printed Bibles were not largely available till the advent of Johannes Gutenberg's printing press in 1440, religious art was crucial in passing on teachings of the faith, and in encouraging reflection on Biblical events and devotion to God.
Despite its rarity, several cases of hematohidrosis have been reported globally and reviewed in the literature in recent years. We performed a search for “hematohidrosis,” “haematohidrosis,” “hematidrosis,” or “haematidrosis” in PubMed for articles published up to January 2023. We excluded cases with chromhidrosis, a rare condition with a presentation of the secretion of colored sweat secondary to dyes, drugs, chromogenic bacteria, fungi, and chemical contactants. Cases of hemolacria (presence of blood in tears), as well as mucosal bleeding (i.e., bleeding from the nose, tongue, or intestinal bleeding), as a single, exclusive site of bleeding were excluded, as these surfaces do not contain sweat glands. Cases presenting only with otorrhagia (bleeding from the ear) were also excluded.
Our preliminary search results comprised 64 articles, of which 42 were included; these yielded 4 case series and 38 case reports with the earliest report from 1918, with most of the cases published in 2008 to 2023 ([Table 1]). A total of 22 articles were excluded, of which 11 articles were in non-English languages, 7 were literature reviews without new case reports, 1 report was on a dog, 1 was a patient with Henoch Schonlein purpura presenting with bloody sweats, 1 was a sole presentation of hemolacria, and 1 article presented four cases of otorrhagia. In total, 48 cases of hematohidrosis were identified from the 42 articles; these comprised predominantly of females (38; 79.2%), with a median age of 12 years, with a trend toward younger patients, with the youngest patient being 2 months, with the majority of patients (41; 81.4%) being younger than 21 years ([Table 2]). A significant proportion of cases originated in India and more specifically in Asia, with few cases from Europe and North America, which was a trend also observed by Kluger.[2] There seems to be increasing literature on hematohidrosis (given the tempo of case reports published) as noted by Duffin,[3] when comparing articles published between 1880 and 1935, and 1952 and 2016. As compared with 76 cases analyzed by Holoubek and Holoubek in 1996 (many of which were from before the 20th century)[4] and 25 cases by Kluger[2] in 2017 and 28 peer-reviewed cases by Duffin[3] in 2017, Carrion-Alvarez et al[5] identified 60 cases; however, this review included cases of trichorrhage (bleeding from hair follicles) and hemolacria. This could be attributed to a true increase in incidence of the condition, or an increase in the recognition or reporting of such cases. As hematohidrosis can be considered a somatization disorder, social and cultural background can also play a part in its occurrence or reporting. In addition, skepticism around its very existence may hinder publication in Western literature.[6] A total of 32 (66.7%) cases were able to identify a triggering event—including a stressful or emotionally stimulating event, or head trauma. Three cases experienced head trauma prior to the bleeding event (cases 24, 33, and 34). Two cases experienced hematohidrosis during exertion (cases 35 and 48). Case 32 identified pressure to the palm by a metal bar as a precipitating factor for hematohidrosis on the palm. Emotional stress seems to be a common precipitating factor among the majority of the cases. A large proportion of cases were precipitated by acute emotional events (e.g., witnessed beheading of a woman, acute emotional distress, or by longer-term emotional stress such as separation from loved ones, bullying, and unemployment). This is consistent with Luke's account where Christ's sweat became like great drops of blood as He prepared Himself for his crucifixion. Jesus Christ also bore similar baseline characteristics to cases of hematohidrosis assessed by modern literature—presenting at the age of 33 years, and with no documented medical history or family history of bleeding disorders. Of interest, 8 (16.7%) cases originate from the Middle East, as did Christ (cases 10, 17, 20, 23, 25, 26, 27, and 42).
Case |
Country of origin |
Sex |
Age |
Triggering event |
Past medical history |
Presentation |
Treatment |
Outcome |
Mechanism |
Biopsy |
Publish date |
Author |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 |
England |
F |
11 |
Frightened by gas explosion in neighboring house a week before bleeding began |
Premature born child |
Bleeding from forehead. Frothy sweats, often secreted rapidly that it seemed to issue in a fine jet and could be heard upon the bedclothes.Prodrome of “sick feeling” in epigastrium |
– |
– |
– |
– |
May 1918 |
Scott[14] |
2 |
Brazil |
F |
9 |
Post strenuous exercise and prolonged exposure to heat |
– |
3 episodes witnessed by medical staff of erythematous secretions noted on upper lip 30 min after ambient temperature was raised |
No treatment |
Spontaneous improvement after ambient temperature reduced |
Minor fistula between small blood vessels and sweat glands |
Small, congested periglandular capillaries with no obvious red blood cell extravasation |
January 2008 |
Carvalho et al[7] |
3 |
Thailand |
F |
14 |
None |
No |
Episodes of prodromal body soreness followed by bloody secretions on the palms, soles, scalp, arms, legs, and trunk for 1.5 y |
Lorazepam |
Cessation of bleeding |
Stress-induced vasoconstriction leading to vascular rupture and blood extravasation |
Focal collection of red blood cells in follicular lumens near the orifices Inconspicuous loosening areas caused by separation of collagen fibers, containing fibrin and red blood cells scattered in dermis, especially near hair follicles |
April 2008 |
Manonukul et al[13] |
4 |
India |
F |
12 |
Witnessed beheading of woman in village |
No |
Prodromal sensation of a tingling sensationBright red secretions from the forehead and umbilical region |
Tricyclic antidepressants |
Reduced frequency and severity of episodes |
– |
– |
May 2009 |
Bhagwat et al[8] |
5 |
India |
M |
72 |
Emotional stress due to family |
Depressive disorder |
Bloodstains on undergarmentsNo eyewitness accounts of bleeding |
No treatment |
Spontaneous cessation of bleeding |
Sympathetic mediated constriction followed by dilation causing periglandular vessel rupture and extravasation of blood into sweat glands |
Normal skin biopsy |
July 2009 |
Jerajani et al[9] |
6 |
India |
F |
13 |
None |
PF3 dysfunction |
Bleeding from gums, hematuria, gastrointestinal bleeding |
– |
– |
Sympathetic mediated constriction followed by dilation causing periglandular vessel rupture and extravasation of blood into sweat glands |
– |
September 2009 |
Mishra[15] |
7 |
India |
M |
13 |
None |
– |
Self-resolving 1-min episodes of daily blood sweats (arms, trunk, ear) |
Alprazolam, 20% aluminum hexahydrate in alcohol.Alternate therapy including breathing exercises |
Alprazolam and aluminum hexahydrate were ineffective. Patient reported reduction in episodes with the alternate therapy |
Dermal stromal weakness |
– |
July 2010 |
Patel and Mahajan[16] |
8 |
China |
F |
13 |
Emotional excitement or spontaneously |
– |
Bleeding from tongue, subungual area, palms, feet, thighs, trunk, forehead skin |
Vitamin CCarbazochrome sodium sulfonateDiazepamPropranolol |
Cessation of bleeding with propranolol |
Sympathetic nervous system related |
Normal sweat glands containing no blood, unobstructed blood capillaries, some minor blood extravasation from capillaries, areas of loosening of tissue in dermis |
December 2010 |
Wang et al[17] |
9 |
India |
F |
10 |
Stress from examinations |
– |
3-mo history of recurrent hemolacria, hematohidrosis, and epistaxis, there was a prodrome of soreness at areas that would sweat blood (forehead, ear, neck umbilicus) |
Propranolol, lorazepam |
Lorazepam was stopped due to side effects, reduced episodes with propranolol |
Sympathetic mediated constriction followed by dilation causing periglandular vessel rupture and extravasation of blood into sweat glands |
– |
January 2012 |
Praveen and Vincent[18] |
10 |
Saudi Arabia |
F |
18 |
High stress |
– |
6-mo history of intense headache with abdominal pain followed by mucocutaneous bleeding from the nose, lacrimal ducts, forehead, hands, nails, navel |
Beta-blockers |
Reduction in frequency |
Defects in the dermis create blood-filled spaces that exude onto skin surface |
Normal skin biopsy |
February 2013 |
Mora and Lucas[19] |
11 |
Pakistan |
F |
35 |
Crying during emotional outburst, voluntarily |
– |
5 y of bleeding from eyes and ears |
Propranolol Psychotherapy |
Improvement without cure |
– |
– |
April 2013 |
Khalid et al[20] |
12 |
India |
F |
12 |
None |
No |
1-mo episode of skin bleeding from face, limb, palm, sole |
Diazepam Propranolol |
No response to diazepam. Episodes stopped following 6-d treatment with propranolol with no further recurrence |
– |
Irregular acanthosis of epidermis with broadening of rete pegs along with hypergranulosis and marked hyperkeratosis with edema or superficial dermis.No abnormality in sweat or sebaceous gland |
July 15, 2013 |
Bhattacharya et al[21] |
13 |
India |
F |
12 |
None |
– |
2 y of bleeding from intact skin over forehead, scalp, cheek, nose, and trunk |
Atropine transdermal patch |
Cessation of bleeding |
Sympathetic mediated constriction followed by dilation causing periglandular vessel rupture and extravasation of blood into sweat glands |
Normal skin biopsy |
November 2013 |
Biswas et al[22] |
14 |
India |
M |
10 |
None |
Oppositional defiant disorder |
Bleeding from navel, eyes, ears, and nose |
Lorazepam Propranolol |
Cessation of bleeding |
Sympathetic mediated constriction followed by dilation causing periglandular vessel rupture and extravasation of blood into sweat glands |
– |
July 2014 |
Deshpande et al[23] |
15 |
China |
F |
9 |
Recurred during incident following physical fight with another girl |
Epilepsy |
6-mo history of diffuse bloody sweat sometimes preceded by white frothing from tongue and umbilicus. Episodes were followed immediately by headaches and abdominal pain. Some episodes were also followed by epileptic tonic seizures |
Diazepam and propranolol followed by oxcarbazepine |
Diazepam and propranolol were ineffective. Oxcarbazepine prevented relapse |
Sympathetic mediated pathology |
Normal skin biopsy |
April 2015 |
Shen et al[24] |
16 |
Brazil |
F |
18 |
None |
Conversion, dissociative, and generalized anxiety disorders |
6-y history of spontaneous bleeding from dorsum and palms of hands, forehead, and tear ducts. Coincided with high blood pressure peaks (180–90) |
Atenolol |
Cessation of episodes, with sporadic return on irregular consumption of meds |
Sympathetic mediated pathology |
Normal skin biopsy |
December 2015 |
Uber et al[25] |
17 |
Kuwait |
F |
12 |
None |
Menarche at 10 y old, regular for 4 mo, stopped for 2 y then returned spontaneously |
2 wk of bleeding from left side of face, left eye, and tear duct |
– |
– |
Stress-induced constriction, dilation, and rupture of blood vessels around sweat glands |
– |
March 2016 |
Jafar and Ahmad[26] |
18 |
Thailand |
M |
9 |
None |
– |
Multiple episodes of short self-resolving bloody sweats across the scalp, palms, cheeks, arms, and legs |
No treatment |
Spontaneous resolution |
Sympathetic mediated pathology |
Normal skin biopsy |
August 2016 |
Techasatian et al[27] |
19 |
India |
F |
10 |
Fought with classmate and was punished |
Mixed anxiety and depressive disorder |
Bloody secretion from scalp for 1 wk |
Imipramine and clonazepam for mixed anxiety and depressive disorder. Taught relaxation exercises |
Reduction in frequency and stopped completely |
– |
Normal skin biopsy |
January 2017 |
Jayaraman et al[28] |
20 |
Turkey |
F |
11 |
Head trauma the day prior |
– |
Bleeding on right side of forehead |
Topical adrenaline |
Cessation of bleeding |
Trauma causing ruptured periglandular vessels to leak blood into eccrine gland |
– |
February 2017 |
Yeşilova et al[29] |
21 |
Italy |
F |
21 |
None |
Major depressive disorder, panic disorder |
3-y history of self-limited blood sweats from palms and face. Associated with symptoms in line with depressive disorder and panic disorder |
Paroxetine Clozapine Propranolol |
Propranolol led to reduction in episodes |
Abnormal periglandular sympathetic constriction followed by dilation leading to exudation of blood into eccrine glands |
– |
October 2017 |
Maglie and Caproni[30] |
22 |
Italy |
F |
15 |
None |
Major stressful experience of Abruzzo earthquake 9 y earlier |
3-mo history of mucocutaneous bleeding. Sometimes preceded by headaches and asthenia |
Propranolol |
Cessation of bleeding |
– |
– |
February 2018 |
Ricci et al[31] |
23 |
Saudi Arabia |
F |
9 |
Bullied in school |
– |
Bloody secretions from skin, scalp, ear, mouth, eyes twice weekly |
Propranolol |
Cessation of bleeding |
Constriction, dilation, and rupture of blood vessels mediated by sympathetic nervous system. Defects in dermis causing stromal weakness, communicating with vascular spaces in dermis |
– |
April 2018 |
Alsermani et al[1] |
24 |
Iran |
F |
11 |
Extreme emotional stress |
– |
Prodromal abdominal pain, vomiting and headache. Frothy, bloody secretions from forehead, eyes, ears, nails, arm, umbilicus, back, vagina, GIT |
Psychotherapy Propranolol |
Reduced frequency and severity of episodes |
Intensified sympathetic activation leading to constriction and dilation of blood vessels, and subsequent rupture. Dermal vasculitis and defects in the dermis, due to stromal weakness |
– |
November 2018 |
Shahgholi[32] |
25 |
Iran |
M |
8 |
Upcoming exam, playing computer games, watching fiction TV movies, parents not satisfying demands |
– |
Painless spontaneous bloody secretions from nail beds of hands and feet |
No treatment |
Spontaneously resolved without intervention |
– |
|||
26 |
Iran |
F |
9 |
None |
– |
Bloody nonviscous secretions from ear lobes, nose, and eyes |
Propranolol |
Resolution of episodes |
Constriction and rupture of blood vessels under stress |
– |
||
27 |
India |
F |
10 |
None |
– |
5 d of bleeding from forehead and chest |
No treatment |
No further bleeding |
– |
– |
May 2019 |
Pari[33] |
28 |
Sweden |
M |
9 |
None |
– |
Bloody sweat from head and neck with headache. Headache was reported to shift locations and was hypersensitive to light and sound. There was a reported prodrome of paresthesia at areas that would bleed |
Propranolol |
Reduction in episodes |
Sympathetic stimulation of vessels causing constriction leads to blood extravasation |
– |
June 2019 |
Hansson et al[34] |
29 |
Germany |
F |
10 |
Emotional and general distress. Recent head trauma |
– |
Prodrome of headache followed by spontaneous bloody secretion from right forehead |
Psychiatric support |
Ineffective |
– |
– |
November 2019 |
Meyer et al[35] |
30 |
India |
F |
15 |
Head trauma |
– |
2-wk history of bleeding from ears and nose with hemolacria |
Anxiolytics Propranolol |
Reduction in episodes |
Sympathetic mediated constriction followed by dilation causing periglandular vessel rupture and extravasation of blood into sweat glands |
Normal skin biopsy |
January 2020 |
Das et al[36] |
31 |
India |
F |
13 |
Anxiety |
– |
Bleeding from face, forearms and shoulders with hemolacria |
Anxiolytics Propranolol |
Cessation of bleeding |
Sympathetic mediated constriction followed by dilation causing periglandular vessel rupture and extravasation of blood into sweat glands |
Normal skin biopsy |
||
32 |
Japan |
F |
6 |
Pressure to palm while playing with horizontal bar or spontaneously with no identifiable trigger |
– |
Bloody aqueous secretions from palm |
Tap water iontophoresis |
Cessation of bleeding |
– |
Atrophy and low number of gross cystic disease fluid protein-15-positive eccrine sweat glands. Increased CD-43-positive cells around eccrine sweat glands |
February 2020 |
Murota et al[37] |
33 |
Japan |
F |
11 |
None |
Dissociative disorder and self-harm |
Bloody secretion from forehead, hands, feet, scalp associated with pain |
Propranolol |
Cessation of bleeding |
Blood vessel rupture around sweat glands |
No obvious abnormalities apart from microvessels adjacent to sweat glands |
August 2020 |
Matsuoka and Tanaka[38] |
34 |
India |
F |
15 |
Stress, anxiety, exercise |
AD optical atrophy |
5-y history of average 5 episodes daily of bloody secretion from mouth. 4 concomitant episodes of hemolacria reported |
Propranolol and psychological counseling |
Reduction in daily episodes from 5 to 0–2 |
Adrenaline-induced constriction of periglandular vessels, followed by an exacerbated dilatation which allows blood to fill the eccrine ducts |
– |
November 2020 |
Corrà et al[39] |
35 |
French |
F |
22 |
During intense physical exertion. Reported considerable stress during COVID-19 pandemic containment period |
– |
Bleeding from forehead. A vascular pathway appeared to remain apparent for 24 h |
No treatment |
No further bleeding |
– |
– |
November 2020 |
Récher[40] |
36 |
Mexico |
M |
22 |
Acute emotional distress |
– |
Episodes of bloody secretion from the head associated with pain and hemolacria since 6 y of age |
Anxiolytics Propranolol |
Ineffective |
Genetic mutations related to ECM function and development that affects vessel integrity and formation, and in coagulation events |
Histological examination showed capillary dilation, associated with vascular congestion and slight extravasation of blood |
March 2021 |
Salas-Alanis et al[41] |
37 |
Africa |
M |
9 |
None |
Malaria, HIV, hepatitis B |
Bleeding from eyes, gums, axillae, umbilicus, intermittent hematochezia, hematemesis, hematuria. Began when developed malaria but continued despite completing treatment for malaria |
Propranolol Vitamin C supplementation Oxymetazoline Natural tears |
Reduction in frequency |
Blood vessels around sweat gland constrict under pressure induced by exogenous stressor, then dilate to point of rupture and extravasation of blood |
Intradermal bleeding and obstructed capillaries.No abnormalities in sweat glands, hair follicles, and sebaceous glands.Multiple blood-filled spaces in dermis opening directly into follicular canals or skin surface |
March 2021 |
Hoover et al[42] |
38 |
Africa |
F |
2 mo |
None |
Sister to above boy. Mother's sibling passed away due to unidentified bleeding complication |
Spontaneous bleeding from eyelids, ears, hairline |
Propranolol |
Improvement with reduced frequency and duration of bleeding |
– |
– |
||
39 |
India |
F |
13 |
None |
Recurrent panic attacks with tachycardia |
Bloody secretions from her nose and palmar creases for the past 3 mo |
Anxiety disorder already being treated with propranolol, valproic acid, and sertraline. Oxybutynin |
Cessation of condition |
Possible defects in dermis causing stromal weakness that communicated with vascular spaces. Blood exuded via follicular channels or directly onto skin surface |
– |
July 2021 |
Tirthani et al[43] |
40 |
USA |
F |
10 |
Psychosocial stress due to recent separation of parents |
– |
3-mo history of episodic blood-like discharge from all over the body |
Propranolol Cognitive behavioral therapy |
Resolution of episodes with no recurrence |
Constriction of blood vessels around sweat glands, followed by a rapid dilation and rupture, causing extravasation of blood into the sweat glands Defects in dermis that intermittently fill with blood and exude contents to skin surface |
– |
September 2021 |
Shafique et al[44] |
41 |
India |
M |
12 |
Adjustment disorder due to separation from aunt |
Adjustment disorder due to separation from aunt |
Blood-stained tears, epistaxis and bleeding from ear and mouth. Burning sensation, irritation, redness of eyes before bleeding. One episode of hematuria and hematochezia |
Psychiatric therapy. Propranolol |
Complete recovery |
Blood vessels around sweat glands constrict in response to stress, then dilate to the point of rupture. Dermal defects causing stromal weakness, communicating with vascular spaces that exude blood onto skin surface |
– |
November 2021 |
Talwar et al[45] |
42 |
Saudi Arabia |
F |
20 |
None |
Menorrhagia few months, fibroadenoma 6 mo, neurological symptoms, sinus tachycardia |
Gum bleeding, mild ear bleeding, epistaxis for 4 mo |
Propranolol |
Reduction in frequency of episodes |
High vascular pressure causing blood to pass into ducts of sweat glands. Dermal vessel vasculitis |
Slightly prominent blood vessel adjacent to sweat gland |
January 2022 |
Alasfoor et al[46] |
43 |
China |
F |
8 |
Induced by slight trauma, external stimulus, emotional excitement, or during class |
– |
Epistaxis without pain, bleeding from corner of eyes, forehead, oral, arms, legs, and intestine |
Vitamin C Carbazochrome tables Carbazochrome sodium sulfonate Vitamin K1 Propranolol Oryzanol Compound rutin tablets. Pharmacotherapy discontinued. Patient was removed from school and encouraged leisure activities and strengthening of mentality |
Medical therapy showed no improvement. Cessation of bleeding episodes with conservative management |
Sympathetic induced capillary relaxation and rupture causing bleeding |
Skin histopathology showed subcutaneous bleeding and capillary clogging, suggesting vasculitis |
June 2022 |
Zheng et al[47] |
44 |
India |
F |
18 |
Sometimes during eating and sleeping. Coincided with school examinations. Episodes of hemoptysis 2 y prior, undiagnosed etiology |
– |
Bleeding from eyes, ear, nose, and mouth. Tingling sensation before episodes |
Fluoxetine Clonazepam Propranolol Olanzapine |
Reduction of episodes but still persistent. Cessation of bleeding with addition of Olanzapine |
– |
– |
July 2022 |
Biswas et al[48] |
45 |
India |
F |
21 |
Untimely demise of father, feeling low. Episodes followed stressors at home |
– |
Bleeding from eyes and facial skin |
Fluoxetine Clonazepam Olanzapine |
Cessation of bleeding |
– |
– |
||
46 |
India |
F |
20 |
Friend of case 45, developed similar symptoms upon knowing of case 45's symptoms |
– |
Bleeding from ear and axial skin |
Benzodiazepines |
Cessation of bleeding |
– |
– |
||
47 |
India |
M |
14 |
Coincided with school examinations |
Mixed anxiety and depressive disorder |
1 y of bleeding from nose, forehead, scalp, eyes (nonconjunctival), ear, cheeks, limbs, trunk. Reported prodrome of generalized itching |
Adenoidectomy Sertraline Behavioral therapy |
Cessation of bleeding |
Sympathetic activation of capillary network around sweat glands, causing dilating and rupture leading to localized hemorrhage |
Normal skin biopsy.Enlarged adenoids |
September 2022 |
Mitra et al[49] |
48 |
USA |
F |
19 |
During times of exertion, exercising |
Epilepsy, juvenile absence seizures |
1 y of bloody sweat from bilateral axillary regions, forearms |
Declined treatment |
Continues to experience same symptoms |
– |
– |
March 2023 |
Ogbuneke and Allen[50] |
Nine cases had been diagnosed with some form of psychiatric illness, including mixed anxiety and depression disorder (case 47), adjustment disorder (case 41), dissociative disorder (case 16), and oppositional defiant disorder (case 14). The caveat here is that many of the cases did not receive a formal psychiatric assessment; thus, it is difficult to build a strong association with psychiatric illnesses and hematohidrosis.
Of the 48 cases reviewed, 21 (43.8%) had skin biopsies performed, of which 10 showed various abnormalities such as congested capillaries (cases 2, 37, 38, 43). Areas of loosening of tissue in the dermis were also seen in some studies (cases 3, 8). Notably, blood-filled spaces in the dermis opening directly into follicular canals or skin surface were seen in cases studied by Hoover et al (Case 37, 38). This is consistent with the well-agreed mechanism of hematohidrosis caused by dermal defects that become filled with blood, which is supported by smear of blood secretion[7] [8] and benzidine testing[9] that showed normal components of sweat with some red blood cells. A total of 37 (77.1%) cases were treated using pharmacotherapy. Beta-blockers were commonly used to treat hematohidrosis, with 26 (33.7%) cases treated with β-blockers (most commonly propranolol) of which 23 observed a good response with resolution of hematohidrosis. Of these 23, four cases employed simultaneous psychotherapy of some form, and observed good response. Benzodiazepines were also commonly used, with 12 (15.6%) patients receiving benzodiazepines such as lorazepam, clonazepam, or alprazolam. Six cases observed a good response; 4 of these cases were treated in conjunction with other medical therapy. Four cases saw no response to benzodiazepines. One case stopped lorazepam due to side effects. Unspecified anxiolytics with propranolol were used in three (3.9%) cases, with two having a good response. Seven cases had spontaneous resolution without treatment, including one case that did not respond to medical therapy but seemed to improve when all medical therapy was withdrawn, and the patient was withdrawn from school and encouraged “strengthening leisure activities and adjusting mentality” (case 43).
The proposed pathophysiology of hematohidrosis can be broadly divided into adrenergic, structural, and genetic causes. The most common postulated adrenergic-related mechanism is related to the constriction of the vessels in the dermal plexus around the eccrine glands. According to previous studies on the vasculature of eccrine glands,[10] it is likely that the arterioles constrict during stressful periods due to sympathetic nervous activation, followed by dilation to the point of rupture.[9] For Jesus Christ, Zugibe[11] postulated that this dilation was caused by a counterreaction by the parasympathetic nervous system in response to Jesus' acceptance of His fate. When blood rushes back into the delicate capillaries, this causes them to rupture into the sweat gland tubules, mixing blood with the increased amount of sweat that extrudes to the surface of the skin. The good response to β-blockers with resolution of hematohidrosis also supports the role that the sympathetic nervous system plays. Another sympathetic-mediated mechanism that we would like to propose is the role of adrenaline-associated endothelial damage. Certain metabolites have been found to exhibit a dose–response relationship with the adrenaline–noradrenaline equimolar treatment.[12] These 46 metabolites align with the glutathione–ascorbate cycle and nitric oxide biosynthesis pathway. Upon catecholamine stimulation, an increase in glucose consumption and aerobic respiration was observed in endothelial cells, which supports how catecholamine stimulation of endothelial cells can cause increased oxidative stress and nitric oxide metabolism, and is associated with increased vascular permeability. The use of β-blockers also supports this as they antagonize the action of adrenaline and noradrenaline, particularly in blood vessels. A structural mechanism that was postulated is that defects in the dermis result in structural stromal weaknesses that can communicate with vascular spaces in the dermis. When these vascular spaces are filled with blood, pressure on the dermis causes blood to exude onto the skin surface.[13]
Lastly, we would like to also raise the possibility of genetic predispositions to hematohidrosis. Geographically, as noted previously by Kluger,[2] the condition seems to be more prevalent in Asiatic regions compared with Western regions. Genetic testing performed in case number 36, a young 22-year-old male patient with previous episodes of bloody secretion from the head associated with pain and hemolacria since 6 years of age, showed pathogenic variants related to the extracellular matrix (ECM), such as different types of collagen chains, a disintegrin and metalloproteinase (ADAM), metallopeptidases, laminins, integrins, matrix metallopeptidases, mucins, and von Willebrand factor. Genetic mutations related to ECM function and development can affect vessel integrity and formation and can lead to a bleeding phenotype.[5] Cases 37 and 38 are siblings, suggesting potential familial association in patients who experience hematohidrosis. The mother of cases 37 and 38 is reported to have a sibling who passed away due to some unknown bleeding complication, potentially additionally suggestive of familial association in cases of hematohidrosis.
The limitations of our review include the heterogenous reporting of cases, with some cases lacking histopathological proof or laboratory evaluation to exclude coagulopathy by performing standard coagulation tests. As such, the pathophysiology of hematohidrosis cannot be convincingly elucidated. Furthermore, skin biopsies and adrenaline sampling were not done during the time of bleeding but performed after the cessation of bleeding. As such, pathological changes to the dermis, eccrine glands, and blood capillaries might have resolved, leading to inconclusive skin biopsy findings.[9] Similarly, we are unable to corroborate the hypothesized mechanism of adrenaline-associated endothelial damage with biochemical evidence. Lastly, most cases did not have genetic testing performed.
In summary, cases of hematohidrosis have been documented throughout history and art, as well as in modern medical literature. Hematohidrosis has previously been perceived with religious mystery and can plausibly be explained for a multitude of reasons.[6] Given our review and the histopathological findings from skin biopsies, we postulate that hematohidrosis is precipitated by periods of extreme stress, resulting in a combination of dilatation and rupture of fine blood vessels supplying eccrine glands, and possibly endothelial damage from adrenaline causing increased vascular permeability. Hematohidrosis in Jesus Christ, as illustrated in 15th century Renaissance art, is a prime example of a young Middle Eastern patient experiencing blood-like sweat, amidst immense mental suffering in the grounds of Gethsemane. Perhaps this is where medicine and biblical scripture can find a common ground, where what was previously regarded as a supernatural phenomenon can now be explained with plausible clinical reality.
Data Availability Statement
All data are presented within the manuscript.
Authors' Contribution
All authors contributed extensively to the creation of this manuscript. B.E.F. conceptualized the review and provided critical revision of the manuscript for important intellectual content.
Publication History
Article published online:
16 May 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Alsermani M, Alzahrani H, El Fakih R. Hematidrosis: a fascinating phenomenon-case study and overview of the literature. Semin Thromb Hemost 2018; 44 (03) 293-295
- 2 Kluger N. Hematidrosis (bloody sweat): a review of the recent literature (1996-2016). Acta Dermatovenerol Alp Panonica Adriat 2018; 27 (02) 85-90
- 3 Duffin J. Sweating blood: history and review. CMAJ 2017; 189 (42) E1315-E1317
- 4 Holoubek JE, Holoubek AB. Blood, sweat and fear. “A classification of hematidrosis”. J Med 1996; 27 (3-4): 115-133
- 5 Carrion-Alvarez D, Trejo-Castro AI, Salas-Garza M, Fajardo-Ramirez OR, Salas-Alanis JC. Hematohidrosis, hemolacria, and “trichorrhage”: a systematic review. Skin Appendage Disord 2022; 8 (03) 179-185
- 6 Favaloro EJ, Lippi G. Commentary: controversies in thrombosis and hemostasis Part 1 - Hematidrosis: “Blood, sweat and fears” or a “pigment of fertile imaginations?”. Semin Thromb Hemost 2018; 44 (03) 296-297
- 7 Carvalho AC, Machado-Pinto J, Nogueira GC, Almeida LM, Nunes MB. Hematidrosis: a case report and review of the literature. Int J Dermatol 2008; 47 (10) 1058-1059
- 8 Bhagwat PV, Tophakhane RS, Rathod RM, Shashikumar BM, Naidu V. Hematohidrosis. Indian J Dermatol Venereol Leprol 2009; 75 (03) 317-318
- 9 Jerajani HR, Jaju B, Phiske MM, Lade N. Hematohidrosis - a rare clinical phenomenon. Indian J Dermatol 2009; 54 (03) 290-292
- 10 Kennedy WR, Wendelschafer-Crabb G, Brelje TC. Innervation and vasculature of human sweat glands: an immunohistochemistry-laser scanning confocal fluorescence microscopy study. J Neurosci 1994; 14 (11, Pt 2): 6825-6833
- 11 Zugibe FT. The Crucifixion of Jesus, Completely Revised and Expanded: A Forensic Inquiry. 2nd ed. M. Evans& Co Inc; 2005: 11-15
- 12 López García de Lomana A, Vilhjálmsson AI, McGarrity S. et al. Metabolic response in endothelial cells to catecholamine stimulation associated with increased vascular permeability. Int J Mol Sci 2022; 23 (06) 3162
- 13 Manonukul J, Wisuthsarewong W, Chantorn R, Vongirad A, Omeapinyan P. Hematidrosis: a pathologic process or stigmata. A case report with comprehensive histopathologic and immunoperoxidase studies. Am J Dermatopathol 2008; 30 (02) 135-139
- 14 Scott CT. A case of haematidrosis. BMJ 1918; 1 (2993): 532-533
- 15 Mishra KL. Bloody tears and hematohidrosis in a patient of PF3 dysfunction: a case report. Cases J 2009; 2: 9029
- 16 Patel RM, Mahajan S. Hematohidrosis: a rare clinical entity. Indian Dermatol Online J 2010; 1 (01) 30-32
- 17 Wang Z, Yu Z, Su J. et al. A case of hematidrosis successfully treated with propranolol. Am J Clin Dermatol 2010; 11 (06) 440-443
- 18 Praveen BK, Vincent J. Hematidrosis and hemolacria: a case report. Indian J Pediatr 2012; 79 (01) 109-111
- 19 Mora E, Lucas J. Hematidrosis: blood sweat. Blood 2013; 121 (09) 1493
- 20 Khalid SR, Maqbool S, Raza N, Mukhtar T, Ikram A, Qureshi S. Ghost spell or hematohidrosis. J Coll Physicians Surg Pak 2013; 23 (04) 293-294
- 21 Bhattacharya S, Das MK, Sarkar S, De A. Hematidrosis. Indian Pediatr 2013; 50 (07) 703-704
- 22 Biswas S, Surana T, De A, Nag F. A curious case of sweating blood. Indian J Dermatol 2013; 58 (06) 478-480
- 23 Deshpande M, Indla V, Kumar V, Reddy IR. Child who presented with hematohidrosis (sweating blood) with oppositional defiant disorder. Indian J Psychiatry 2014; 56 (03) 289-291
- 24 Shen H, Wang Z, Wu T. et al. Haematidrosis associated with epilepsy in a girl successfully treated with oxcarbazepine: case report. J Int Med Res 2015; 43 (02) 263-269
- 25 Uber M, Robl R, Abagge KT. et al. Hematohidrosis: insights in the pathophysiology. Int J Dermatol 2015; 54 (12) e542-e543
- 26 Jafar A, Ahmad A. Child who presented with facial hematohidrosis compared with published cases. Case Rep Dermatol Med 2016; 2016: 5095781
- 27 Techasatian L, Waraasawapati S, Jetsrisuparb C, Jetsrisuparb A. Hematidrosis: a report with histological and biochemical documents. Int J Dermatol 2016; 55 (08) 916-918
- 28 Jayaraman AR, Kannan P, Jayanthini V. An interesting case report of hematohidrosis. Indian J Psychol Med 2017; 39 (01) 83-85
- 29 Yeşilova Y, Turan E, Aksoy M. Hematidrosis on the forehead following trauma: a case report. Int J Dermatol 2017; 56 (02) 212-214
- 30 Maglie R, Caproni M. A case of blood sweating: hematohidrosis syndrome. CMAJ 2017; 189 (42) E1314
- 31 Ricci F, Oranges T, Novembre E. et al. Haematohidrosis treated with propranolol: a case report. Arch Dis Child 2019; 104 (02) 171
- 32 Shahgholi E. A case series of hematohidrosis: a puzzling medical phenomenon. Turk J Pediatr 2018; 60 (06) 757-761
- 33 Pari T. Hematohidrosis - a rare case. Indian Dermatol Online J 2019; 10 (03) 334-335
- 34 Hansson K, Johansson EK, Albåge M, Ballardini N. Paediatric haematohidrosis: an overview of a rare but clinically distinct condition. Acta Paediatr 2019; 108 (06) 1023-1027
- 35 Meyer J, Spacil K, Stehr M, Hinrichs W, Haller S, Schäfer FM. Hematidrosis after head injury - a case report. Klin Padiatr 2019; 231 (06) 326-327
- 36 Das D, Kumari P, Poddar A, Laha T. Bleeding to life: a case series of hematohidrosis and hemolacria. Indian J Pediatr 2020; 87 (01) 84
- 37 Murota H, Kotobuki Y, Yamaga K, Yoshioka Y. Female child with hematidrosis of the palm: case report and published work review. J Dermatol 2020; 47 (02) 166-168
- 38 Matsuoka R, Tanaka M. Hematidrosis in a Japanese girl: treatment with propranolol and psychotherapy. Pediatr Int 2020; 62 (08) 1001-1002
- 39 Corrà A, Quintarelli L, Caproni M. Bleeding from the oral cavity: a new case of hematohidrosis. Int J Dermatol 2020; 59 (11) e421-e422
- 40 Récher C. Hematidrosis as a manifestation of COVID-19 containment-induced stress. eJHaem 2020; 2 (01) 25
- 41 Salas-Alanis JC, Salas-Garza M, Goldust MM, Fajardo-Ramirez OR. Haematidrosis and haemolacria in a young adult. Clin Exp Dermatol 2021; 46 (02) 394-396
- 42 Hoover A, Fustino N, Sparks AO, Rokes C. Sweating blood: a case series of 2 siblings with hematohidrosis. J Pediatr Hematol Oncol 2021; 43 (02) 70-72
- 43 Tirthani K, Sardana K, Mathachan SR. Hematohidrosis of the mid-face and hands treated with oral oxybutynin. Pediatr Dermatol 2021; 38 (04) 962-963
- 44 Shafique DA, Hickman AW, Thorne A, Elwood HR, Zlotoff BJ. Pediatric hematidrosis - a case report and review of the literature and pathogenesis. Pediatr Dermatol 2021; 38 (05) 994-1003
- 45 Talwar M, Chidambaram AC, Mekala S, Parameswaran N, Delhikumar CG. Haematohidrosis in a 12-year-old boy: blood, sweat and tears. Paediatr Int Child Health 2021; 41 (04) 300-302
- 46 Alasfoor S, Albashari M, Alsermani A, Bakir M, Alsermani M, Almustanyir S. A strange occurrence of hematohidrosis: a case report from Saudi Arabia. Cureus 2022; 14 (01) e21682
- 47 Zheng J, Bian MR, Wu XQ. et al. Hematidrosis: a case report. Dermatol Ther 2022; 35 (06) e15462
- 48 Biswas D, Mondal DK, Biswas R, Halder A. Hematidrosis: a rare entity - case series and review of literature. Indian J Psychiatry 2022; 64 (04) 423-425
- 49 Mitra S, Chatterjee SS, Roy S, Kumar M. Stress-induced haematohidrosis: a case report. East Asian Arch Psychiatry 2022; 32 (03) 62-63
- 50 Ogbuneke JU, Allen JC. Case report and review of the pathophysiology and therapeutics of adult hematohidrosis. Cureus 2023; 15 (03) e36187